Sargent Bickham Lagudis LLC Covetrus, Inc. Transaction History

Sargent Bickham Lagudis LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 27, 2022	SELL	$20.69 - $20.91 $4,013 - $4,056	-194 Reduced 91.94%	17 $0
Q2 2022 Jul 13, 2022	SELL	$13.8 - $20.82 $993 - $1,499	-72 Reduced 25.44%	211 $4,000
Q3 2021 Nov 05, 2021	SELL	$18.14 - $27.03 $1,306 - $1,946	-72 Reduced 20.28%	283 $5,000
Q1 2021 May 24, 2021	SELL	$28.29 - $39.89 $622 - $877	-22 Reduced 5.84%	355 $11,000
Q4 2020 May 24, 2021	SELL	$24.45 - $31.59 $537 - $694	-22 Reduced 5.84%	355 $11,000
Q4 2020 May 24, 2021	BUY	$24.45 - $31.59 $537 - $694	22 Added 6.2%	377 $11,000
Q2 2020 Sep 07, 2021	SELL	$6.46 - $19.27 $2,254 - $6,725	-349 Reduced 48.07%	377 $7,000
Q1 2020 Sep 07, 2021	BUY	$5.64 - $15.23 $1,928 - $5,208	342 Added 89.06%	726 $6,000
Q4 2019 Sep 14, 2021	SELL	$8.8 - $14.93 $2,631 - $4,464	-299 Reduced 43.78%	384 $5,000
Q3 2019 Sep 14, 2021	SELL	$11.76 - $25.57 $131,547 - $286,026	-11,186 Reduced 94.25%	683 $8,000
Q2 2019 Sep 13, 2021	SELL	$22.88 - $33.27 $75,504 - $109,791	-3,300 Reduced 21.75%	11,869 $290,000
Q1 2019 Sep 13, 2021	BUY	$31.52 - $46.19 $478,126 - $700,656	15,169 New	15,169 $483,000

72.9K

Ticker CVET
Exchange NASDAQ
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 140,123,008
Description
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vacc...

Get notified when there are updates to the investment portfolio of Sargent Bickham Lagudis LLC, based on Form 13F filings with the SEC.

Stay updated on Sargent Bickham Lagudis LLC with notifications on news.